PCMA Statement on Oversight Committee Hearing on EpiPen Price Hikes
September 21, 2016
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on today’s House Committee...
Filter by:
Formulary Design
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA Statement on New IMS Health Drug Spending Report
April 14, 2016
(Washington, D.C.)— Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on a new...
Research: Medicaid Pharmacy Savings Opportunities: National and State-Specific Estimates
May 02, 2013
Executive Summary This study explores how more efficient pharmacy benefits management—apart from drug manufacturer rebates—could save Medicaid an additional...
PCMA Statement on Essential Health Benefits Proposed Rule
November 20, 2012
The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Department of Health and Human Services...
PCMA Outlines $100 Billion in Prescription Drug Savings to Help Avoid Sequestration Budget Cuts
October 08, 2012
As policymakers are faced with reducing future projected budget deficits by $1.2 trillion through 2021 as part of sequestration,...
New Study Finds Generic Medications Saved $1 Trillion Over the Last Decade
August 02, 2012
The American health care system saved more than $1 trillion through the use of generic medicines over the last decade,...
PCMA Statement on HHS Essential Health Benefits Bulletin
December 19, 2011
(Washington, DC)— The Pharmaceutical Care Management Association (PCMA) released the following statement on the recently released Essential Health Benefits...
November 03, 2011
(Washington, DC)— If Massachusetts repeals its law banning prescription brand drug “copay coupons,” costs for employers, unions and state...
November 03, 2011
(Washington, DC)— Prescription copay coupon marketing programs, which lure insured consumers away from generics and toward more expensive brands,...
November 03, 2011
Much has been much written about the strategies that brand drug companies will use to combat the “generic wave”...
PCMA: PBMs Will Save Nearly $2 Trillion in Prescription Drug Costs over the Next Decade
September 19, 2011
(Washington, DC)— Pharmacy benefit managers (PBMs) will save consumers and payers almost $2 trillion in prescription drug costs –...
New Research: PBMs Generating Savings for Plan Sponsors and Consumers
September 19, 2011
Read the full report. Major Findings: Average PBM Savings: From 2012 to 2021, PBMs will save plan sponsors...